Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 208969
Company: AMPHASTAR PHARMS INC

Products on NDA 208969

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
REXTOVY	NALOXONE HYDROCHLORIDE	4MG/SPRAY	SPRAY, METERED;NASAL	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 208969

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/07/2023	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208969Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/208969Orig1s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/29/2023	SUPPL-1	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208969Orig1s001ltr.pdf

Labels for NDA 208969

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/29/2023	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s001lbl.pdf
06/29/2023	SUPPL-1	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s001lbl.pdf
03/07/2023	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s000lbl.pdf